These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2562141)

  • 41. Erythroblastopenia and Parvovirus B19 infection in a healthy child.
    de Las Nieves López MA ; Medina Perez Mf ; Gónzalez Hermoso C
    Haematologica; 2000; 85(E-letters):E07. PubMed ID: 11114822
    [No Abstract]   [Full Text] [Related]  

  • 42. [Familial transient red cell aplasia from parvovirus B-19 infection].
    Salvini F; Tonella M; Carpani G; Scaglioni S; Zuccotti GV
    Pediatr Med Chir; 2002; 24(4):306-7. PubMed ID: 12197091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
    Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
    Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
    [No Abstract]   [Full Text] [Related]  

  • 44. [Erythroblastopenia caused by parvovirus B19, without chronic hemolytic anemia, associated with iron deficiency].
    Frésard A; Jaubert J; Pozzetto B; Couroucé AM; Lucht F
    Presse Med; 1991 Oct; 20(33):1623-4. PubMed ID: 1658771
    [No Abstract]   [Full Text] [Related]  

  • 45. A patient with pure red cell aplasia after allogenic stem-cell transplantation. Parvo B19 infection.
    Berrevoets MA; van der Post RS; Schaap N
    Neth J Med; 2013 Sep; 71(7):370, 374. PubMed ID: 24038564
    [No Abstract]   [Full Text] [Related]  

  • 46. Congenital spherocytic hemolytic anemia in a family presenting with transient red cell aplasia from parvovirus B19 infection.
    Skinnider LF; McSheffrey BJ; Sheridan D; Deneer H
    Am J Hematol; 1998 Aug; 58(4):341-2. PubMed ID: 9692404
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pure red cell aplasia due to parvovirus B19 occurred in a patient with liver cirrhosis C and hepatocellular carcinoma].
    Umekawa Y; Nishishita C; Okamoto E; Okuyama T; Rai T; Ikeda S
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):57-61. PubMed ID: 12601930
    [No Abstract]   [Full Text] [Related]  

  • 48. Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplant.
    Corbett TJ; Saw H; Popat U; MacMahon E; Cohen BJ; Knowles WA; Beard S; Prentice HG
    Bone Marrow Transplant; 1995 Nov; 16(5):711-3. PubMed ID: 8547870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human parvovirus B19-induced transient red cell aplasia in a patient with vitamin B12 deficiency.
    Hashimoto N; Ueda T; Hiraiwa S; Tajiri T; Yokoyama K
    Br J Haematol; 2016 Jun; 173(5):661. PubMed ID: 26970225
    [No Abstract]   [Full Text] [Related]  

  • 50. [Acute eryhtroblastopenia and polyarthralgia associated with human parvovirus infection (PSH-B19)].
    De Caluwé JP; Morinet F; Pérol Y; Burtonboy G
    Acta Clin Belg; 1987; 42(6):437-44. PubMed ID: 2829485
    [No Abstract]   [Full Text] [Related]  

  • 51. Human parvovirus B19-induced aplastic crisis in autoimmune haemolytic anaemia.
    Tomiyama J; Adachi Y; Hanada T; Matsunaga Y
    Br J Haematol; 1988 Jun; 69(2):288-9. PubMed ID: 2839223
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
    Mouthon L; Guillevin L; Tellier Z
    Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation.
    Au WY; Lie AK; Ma ES; Lau GK; Chan EC; Kwong YL
    Transfusion; 2004 Jun; 44(6):946-7. PubMed ID: 15157268
    [No Abstract]   [Full Text] [Related]  

  • 54. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab.
    Sharma VR; Fleming DR; Slone SP
    Blood; 2000 Aug; 96(3):1184-6. PubMed ID: 10910942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human parvovirus B19 in patients with aplastic anemia.
    Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
    Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient.
    Uemura N; Ozawa K; Tani K; Nishikawa M; Inoue S; Nagao T; Uchida H; Matsunaga Y; Asano S
    Eur J Haematol; 1995 Jan; 54(1):68-9. PubMed ID: 7859882
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic human parvovirus B19 infection associated with interstitial lung disease.
    Klar A; Halamish A; Shoseyov D; Cassinotti P; Siegl G; Springer C; Shazberg G; Hurvitz H
    Isr Med Assoc J; 2002 Oct; 4(10):825-6. PubMed ID: 12389353
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transient erythroblastopenia of childhood due to human parvovirus B19 infection.
    Wodzinski MA; Lilleyman JS
    Br J Haematol; 1989 Sep; 73(1):127-8. PubMed ID: 2553096
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection.
    Griffin TC; Squires JE; Timmons CF; Buchanan GR
    J Pediatr; 1991 Jun; 118(6):899-901. PubMed ID: 1645771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.